NeuroVision Imaging, Inc.
Steven Verdooner has an extensive work history in the field of ophthalmic imaging and healthcare technology. Steven started their career in 1984 as the CEO of Ophthalmic Imaging Systems and held this role for over 23 years until April 2007. Following that, they joined Opko Health, Inc. as the Executive Vice President of Instrumentation from April 2007 to January 2008. In 2008, Verdooner became the CEO of Ocular Development, LLC, where they served until February 2011. Lastly, they became the CEO of NeuroVision Imaging, Inc. in December 2010 and continues to hold this position.
Steven Verdooner attended Granada Hills High School & Northern Valley - Demarest from 1975 to 1979. Steven then went on to study at the University of California, Davis from 1979 to 1983, although it is not specified what degree or field of study they pursued.
This person is not in any teams
NeuroVision Imaging, Inc.
NeuroVision is an integrated neuroscience company focused on delivering scientifically validated, diagnostic tests & biomarkers for early detection and monitoring of amyloid pathology related to Alzheimer’s Disease. The company has developed a novel retinal imaging technology, which is currently being utilized in a number of clinical trialsglobally.With access to unique datasets, we provide data aggregation services, analysis, biostatistics, and applications of machine learning algorithms to large repositories of images and other biomarker data seeking to advance the collective understanding and prediction capabilities for neurodegenerative diseases.